Ignite Creation Date:
2025-12-24 @ 9:07 PM
Ignite Modification Date:
2026-02-22 @ 7:22 PM
Study NCT ID:
NCT05425004
Status:
RECRUITING
Last Update Posted:
2025-05-22
First Post:
2022-06-15
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Cabozantinib for Patients With Recurrent or Progressive Meningioma
Sponsor:
Baptist Health South Florida
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
2020-KOT-002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |